Non-bronchodilating Drugs Flashcards

(corticosteroids and LTRAs

1
Q

Corticosteroid routes

A

Inhal, PO, IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glucocorticoids

A

natural (cortisol) or
synthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Corticosteroid MOA

A
  • reduce inflammation
  • enhance action of beta-adrenergic agonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Corticosteroid therepeutic effects

A
  • several weeks before full effect
  • tx of persistent asthma
  • prevent asthma attacks
  • IV tx of acute exacerbation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Corticosteroid nursing implications

A
  • doses must be tapered off when stopping
  • risk of bone suppression (caution in children)
  • may need increased diabetes meds
  • assess for underlying adrenal d/o
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Leukotriene Receptor Antagonists MOA

LTRAs

A
  • prevent leukotrienes from attaching to receptors on immune cells (circulating and in lungs)
  • reduce inflammation
  • decrease mucous secretions
  • reduce vascular permeability
  • prevent mobilization of WBCs into lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LTRA classes

A
  • Zileuton
  • Montelukast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LTRA

Montelukast therapeutic effects

A
  • preventative
  • long term tx of asthma
  • daily dose, PO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LTRA

Montelukast SE

A
  • heachache
  • nausea
  • diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LTRA

Montelukast considerations

what to monitor

A
  • monitor liver function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

LTRA

Montelukast interactions

A

phenobarbital and rifampin
by effecting CYP3A4 metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly